Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
Contacts
Capabilities
Suggested News & Insights
Ninth Circuit Opens Door to FCA Liability for Alleged 340B OverchargesMarch 19, 2026#Market Access: Another Favorable Medical Products Advisory Opinion from HHS-OIG Signals New FlexibilitiesMarch 19, 2026Fourth Circuit Highlights Tougher Path to Dismissal of FCA Cases Post-SuperValuMarch 18, 2026Fifth Circuit Panel Produces Three Opinions Wrestling with Application of First to File BarMarch 13, 2026Sidley Wins a Trio of Awards at the 2026 Benchmark Litigation US AwardsMarch 12, 2026Sidley Advises Verdane in Its Partnership With SmartboxMarch 12, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

